Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trimeris (TRMS) -- Ignore unavailable to you. Want to Upgrade?

To: Pluvia who wrote (92)	9/12/2000 6:10:56 PM
From: Ben Wa	Respond to of 108

Perhaps they were reacting to the beer and chili.

To: Pluvia who wrote (92)	9/13/2000 7:36:21 AM
From: Mark Doms	Read Replies (1) \| Respond to of 108

I posted this as well on the Raging Bull board: Thank goodness Pluvia (someone in Las Vegas) has caught a fundamental error that has fooled Roche, NIH, and, well, just about anybody else in the HIV scientific community (I am not a member of that community, but a close relative is). Pretty amazing, isn't it? Pluvia, as I said before, I hope you lose your shirt--there are many reasons why this stock may go down in the short run, but your "report" won't be one of them. There are a host of interesting questions surrounding this company and it's product pipeline--why is the Phase III trail late in starting, when will the phase I trail results for t-1249 be released and what will they show, how efficacious will Trimeris's fusion technology be against other viruses and when will trails for these medications begin? The list goes on. It used to be the case that the Yahoo board was the best for informed discussion, but no longer, sadly. Mark.